Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Newstrike Brands Ltd NWKRF

"Newstrike Brands Ltd is a licensed producer and cultivator of medical cannabis based in Brantford, Ontario. The company cultivates and sells both forms including dried and fresh marihuana."


OTCPK:NWKRF - Post by User

Comment by Extallioneson Nov 20, 2017 5:11pm
161 Views
Post# 26999334

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:This is risky at .57 like it or not

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:This is risky at .57 like it or notAs far as I can tell, and he can correct me if I'm wrong, his position seems to be as follows:

1) ACB has lock-up agreements with 38% of CMED's shareholders;
2) the lock-up agreements force that 38% to vote against the acquisition of CMED;
3) Fact #2 will make it difficult for CMED to obtain a majority vote to get the acquisition agreement approved by CMED shareholders;
4) If the agreement DOES get approved, he believes the ACB offer may not go through;
5) he believes the ACB offer is what is currently propping up the CMED share price - because the CMED share price only spiked up from $15 once the ACB offer came out; and
6) According to that line of reasoning, the current HIP share price should only be based on the $15.00 valuation of CMED, because that's all it will be if the HIP deal goes through (or so he is arguing).  

It is a reasonable position. 
<< Previous
Bullboard Posts
Next >>